Evaluation of suitable antigens and adjuvant concentration for sublingual immunization to prevent periodontal disease
Evaluation of suitable antigens and adjuvant concentration for sublingual immunization to prevent periodontal disease
复制标题
DOI:
10.1002/osi2.1018
复制
发表时间:
2019-08-01
影响因子:
0.5
通讯作者:
Kurita-Ochiai, Tomoko
中科院分区:
文献类型:
--
作者:
Chang, Emily;Kobayashi, Ryoki;Kurita-Ochiai, Tomoko
The oral cavity is dominated by both mucosal and systemic immune systems, due to the presence of immunoglobulin (Ig)A antibodies (Abs) in saliva and IgG Abs in gingival crevicular fluid. Transmucosally administered vaccines allowing the development of both systemic and local immune responses are thus optimal for preventing oral infections. We assessed the capacity of a mucosal vaccine targeting recombinant HSP6O from Porphyromonas gingivalis (GroEL) to induce protective mucosal immune responses. As the basic experiment, optimal concentrations of GroEL as antigen (Ag) and synthetic oligonucleotides containing unmethylated CpG dinucleotide (CpG ODN) as a mucosal adjuvant for sublingual immunization were examined in mice. GroEL-specific immune responses were observed in sublingual immunization with a combination of GroEL plus cholera toxin or GroEL plus CpG ODN. The optimal concentrations of GroEL and CpG ODN as antigen and adjuvant in sublingual immunization were 3 and 25 mu g per mouse, respectively. These results suggest that the sublingual administration of GroEL plus CpG ODN is effective for inducing mucosal and systemic Ag-specific Ab responses.